CLINICAL_TRIALS
withdrawal
· 2018-10-10
Clinical Trial Update: PCC and Fibrinogen Compared With FFP in PPH [Phase 4]
Summary
A Phase 4 trial comparing PCC and fibrinogen with FFP for postpartum haemorrhage was withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Helsinki University Central Hospital | Conditions: Postpartum Haemorrhage | Phase 4 | Status: WITHDRAWN